SCHEMBL3047764

SCHEMBL3047764

O=C(O)c1ccc2[nH]c(-c3ccc(Cl)c4c3C(=O)NC4)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.49
AURKA O14965 6/20 0.49
CDK1 P06493 1/20 0.49
PARP1 P09874 1/20 0.43
FFAR1 O14842 4/20 0.39
F2 P00734 2/20 0.38
F10 P00742 2/20 0.38
PLG P00747 2/20 0.38
PLAU P00749 2/20 0.38
PRSS1 P07477 2/20 0.38
WEE1 P30291 1/20 0.38
PLAT P00750 1/20 0.38
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
CLK1 P49759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3040142 0.88 KDR (0.50) KDRAURKACDK1PARP1F2
SCHEMBL3046155 0.86 AURKA (0.65) KDRAURKACDK1WEE1
SCHEMBL3042431 0.86 KDR (0.45) KDRAURKACDK1PLAU
SCHEMBL3047573 0.85 KDR (0.46) KDRAURKACDK1PARP1F10
SCHEMBL3041519 0.84 HPGD (0.45) KDRAURKACDK1PARP1FFAR1
SCHEMBL3046947 0.84 AURKA (0.46) KDRAURKACDK1FFAR1
SCHEMBL3048935 0.83 KDR (0.58) KDRAURKACDK1PARP1HRH3
SCHEMBL3034121 0.83 KDR (0.48) KDRAURKACDK1PARP1F10
SCHEMBL3044089 0.83 KDR (0.45) KDRAURKACDK1PARP1F10
SCHEMBL3042291 0.83 KDR (0.42) KDRAURKACDK1FFAR1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
EP-2108642-A1 JAK INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2009-10-14 EP disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 KDR 3226/4885AURKA 2312/4885CDK1 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.